Sage Therapeutics, Inc. (SAGE) Insider Trading & SEC Filings

Updated Jul 16, 2026 · Last SEC filing 2025-07-31

Sage Therapeutics, Inc. (SAGE) — no SEC Form 4 insider filings recorded in the last 90 days. InsiderAlpha tracks every SAGE SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.

About Sage Therapeutics, Inc. (SAGE)

SEC CIK	0001597553

Recent SAGE Insider Transactions (Form 4)

Date	Insider	Role	Transaction	Shares	Price	Value	Filing
2025-07-31	FRATES JAMES M	Insider	J — Other acquisition / disposition	2.8K	—	—	SEC
2025-07-31	Greene Barry E	President and CEO	J — Other acquisition / disposition	46.9K	—	—	SEC
2025-07-31	Greene Barry E	President and CEO	D — Derivative transaction	53.2K	—	—	SEC
2025-07-31	Golumbeski George	Insider	J — Other acquisition / disposition	8.0K	—	—	SEC
2025-07-31	Quirk Michael C.	See Remarks	D — Derivative transaction	25.0K	—	—	SEC
2025-07-31	Quirk Michael C.	See Remarks	D — Derivative transaction	8.0K	—	—	SEC
2025-07-31	Barrett Elizabeth A.	Insider	J — Other acquisition / disposition	3.0K	—	—	SEC
2025-07-31	Benecchi Christopher	Chief Operating Officer	D — Derivative transaction	28.1K	—	—	SEC
2025-07-31	Benecchi Christopher	Chief Operating Officer	D — Derivative transaction	36.4K	—	—	SEC
2025-07-31	Shiferman Gregory L.	See Remarks	J — Other acquisition / disposition	7.2K	—	—	SEC
2025-07-31	Shiferman Gregory L.	See Remarks	D — Derivative transaction	23.7K	—	—	SEC
2025-04-10	Greene Barry E	President and CEO	A — Grant or award	20.0K	$0.00	—	SEC
2025-04-10	Greene Barry E	President and CEO	F — Tax withholding / forfeiture	4.9K	$6.91	$34K	SEC
2024-12-24	Shiferman Gregory L.	See Remarks	F — Tax withholding / forfeiture	79	$5.48	$433	SEC
2024-11-01	Benecchi Christopher	Chief Operating Officer	A — Grant or award	6.2K	$0.00	—	SEC

All transactions sourced from SEC EDGAR Form 4 filings for Sage Therapeutics, Inc. (SAGE). Updated in real time as new filings are submitted to the SEC.

Recent Insider Filings

2025-07-31 — FRATES JAMES M (Insider)
2025-07-31 — Greene Barry E (President and CEO)
2025-07-31 — Germano Geno J (Insider)
2025-07-31 — Golumbeski George (Insider)
2025-07-31 — COLA MICHAEL F (Insider)

Form 4 Transaction Code Reference

SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in SAGE insider filings:

P	Open-market purchase by the insider
S	Open-market sale by the insider
A	Grant, award, or other acquisition from the issuer
M	Exercise or conversion of derivative security (e.g. options)
F	Payment of exercise price or tax liability via share withholding
G	Bona-fide gift of securities
D	Disposition to the issuer (e.g. share buyback participation)
J	Other acquisition or disposition
X	Exercise of in-the-money or at-the-money derivative security
C	Conversion of derivative security
V	Transaction voluntarily reported earlier than required

SAGE Insider Trading — FAQ

What is the latest insider trade for SAGE?: Sage Therapeutics, Inc. (SAGE) had 0 insider filings in the last 90 days, with the most recent on 2025-07-31. InsiderAlpha tracks every Form 4, 10-K, 10-Q, and 8-K filing in real time.
How many insiders are buying SAGE stock?: 0 insider purchases of SAGE were filed in the last 90 days.
How many insiders are selling SAGE stock?: 0 insider sales of SAGE were filed in the last 90 days.
Where can I see SAGE SEC filings (Form 4, 10-K, 10-Q, 8-K)?: InsiderAlpha aggregates every SAGE SEC filing — Form 4 insider transactions, 10-K and 10-Q quarterly reports, and 8-K material event disclosures — in one timeline.

Learn More

Open the live SAGE dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.